Roche Launches Cobas SARS-CoV-2 Variant Test to Detect Emerging Coronavirus Mutations

Shots:

• The company has launched the cobas SARS-CoV-2 variant set 1 test to detect spike mutations in virus variants including UK (B.1.1.7), South Africa (B.1.351), and Brazil (P.1)
• The accurate detection and differentiation of SARS-CoV-2 mutations can aid in assessing the spread of circulating variants and monitor their potential impact on diagnostics, vaccines and therapeutics
• The cobas SARS-CoV-2 variant set 1 test runs on the high-volume cobas 6800/8800 systems and is for research purposes only. The periodic assessments against emerging variants demonstrated Roche’s test is accurate and effective

Click here ­to­ read full press release/ article | Ref: Roche | Image: Spain’s News